BRIEF-Amicus plans to submit Japanese new drug application for Migalastat

* Plans to submit a Japanese new drug application (J-NDA) to request marketing authorization for Migalastat in first half of 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.